Betaferon Prospective Study on Adherence, Coping and Nursing Support.

Trial Profile

Betaferon Prospective Study on Adherence, Coping and Nursing Support.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Sep 2016

At a glance

  • Drugs Interferon beta-1b (Primary)
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms BEACON
  • Sponsors Bayer
  • Most Recent Events

    • 20 Jan 2014 According to ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
    • 28 Oct 2013 Planned end date changed from 1 Oct 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
    • 01 Aug 2013 Planned number of patients changed from 1500 to 1722 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top